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Abstract: An increase in fructose consumption coincides with a rising incidence of metabolic disorders. Dietary fructose 
has been shown to affect hepatic lipid metabolism in a way that may lead to lipid deposition in the liver. In this study, we 
tested the hypothesis that the effects of fructose overconsumption on hepatic lipid metabolism differ between sexes. To that 
end we examined the effects of a high-fructose diet on the expression of key enzymes and transcription factors involved 
in the regulation of fatty acid oxidation and de novo lipogenesis in the liver of 12-week-old male and female Wistar rats. 
Immediately after weaning, the rats were subjected to a standard diet and 10% fructose solution or drinking water for 9 
weeks. The fructose-enriched diet induced hypertriglyceridemia and increased hepatic de novo lipogenesis in both sexes, 
without lipid deposition in the liver. At the same time, visceral adiposity was observed only in female rats, while in males the 
treatment stimulated hepatic fatty acid oxidation. The fructose-enriched diet induced sex-specific effects on hepatic lipid 
metabolism in young rats. These results imply that male and female rats employ different strategies to cope with dietary 
fructose-related energy overload and to avoid lipid accumulation in the liver. 
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INTRODUCTION
Fructose is one of the most frequently used ingredients 
in the food industry. The huge rise in fructose con-
sumption observed in the last decades mostly comes 
from increased consumption of refined sugars and 
not from naturally occurring fructose in fruits. This 
trend runs parallel with the increasing prevalence of 
obesity and related metabolic disorders, which has 
raised interest in the potential role of fructose as a 
factor contributing to the development of metabolic 
disorders. Some authors have suggested that fructose 
overconsumption is associated with increased risk of 
obesity, insulin resistance, metabolic syndrome, type 
2 diabetes, cardiovascular disease and nonalcoholic 
fatty liver disease [1-3], with other authors not fully 
supporting these assertions [4-6]. Studies performed on 
animals have shown that fructose supplementation can 
result in hypertension, insulin resistance, dyslipidemia 
and the accumulation of visceral and ectopic fat [7-9].
Fructose is mainly metabolized in the liver, and a 
high flux of fructose was shown to affect hepatic lipid 
and glucose metabolism in a way that might result in 
ectopic lipid deposition and eventually in hepatosteatosis 
[2]. The high lipogenic potential of fructose stems from 
the generation of lipogenic substrates, triosephosphates 
and acetyl-CoA, as well as from a stimulated expression 
of lipogenic enzymes, including acetyl-CoA carboxy-
lase 1 (ACC1) and fatty acid synthase (FAS), through 
the activation of transcription factors such as sterol 
regulatory element binding protein 1c (SREBP-1c) [10]. 
However, whether fructose overconsumption will lead 
to lipid accumulation in the liver depends on the balance 
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between de novo lipogenesis and fatty acid oxidation, 
and between hepatic lipid intake and secretion [11,12]. 
The expression of genes involved in fatty acid oxidation, 
including carnitine palmitoyltransferase 1 (CPT1), is 
stimulated by a transcription complex that is comprised 
of peroxisome proliferator-activated receptor α (PPARα), 
PPARγ coactivator 1α (PGC-1α) and lipin-1 [13,14].
Previous studies have reported sex-dependent dif-
ferences in the susceptibility to and progression of meta-
bolic disorders [15]. Females appear to be more prone 
to obesity, while males display higher rates of insulin 
resistance-related disorders and nonalcoholic fatty liver 
disease [16, 17]. Studies on adult rats have shown that 
male rats subjected to a high fat diet developed a greater 
degree of hepatic steatosis, while in females the disease 
phenotype was alleviated [17, 18]. Although nonalco-
holic fatty liver disease is predominantly diagnosed in 
adults, pediatric liver diseases are a growing problem. As 
the immature young organism and adult differ largely 
in their metabolic and physiological profiles, it is of 
interest to evaluate the effects of a fructose-rich diet on 
hepatic lipid metabolism in the young population that 
consumes more fructose-enriched drinks as compared 
to adults. Furthermore, the majority of animal studies 
on diet-induced metabolic disorders were performed 
in males, while females are still underrepresented. As a 
consequence, it is not always clear whether the obtained 
results apply equally to both sexes.
In this study, we hypothesized that the effects of a 
fructose-rich diet on hepatic lipid metabolism differ 
between sexes. To test this hypothesis, we measured 
the expression of key enzymes and transcription fac-
tors involved in the regulation of fatty acid oxidation 
and de novo lipogenesis in the livers of both male and 




Male and female 21-day-old Wistar rats were randomly 
divided into two experimental groups (9 animals per 
group) as follows: the control group (C) was fed with 
commercial standard chow and drinking water, and the 
fructose group (F) was fed with the same chow and 10% 
(w/v) fructose solution instead of drinking water. Both 
experimental groups had ad libitum access to food and 
drinking fluid during 9 weeks. The concentration of 
fructose solution was chosen to be similar to the intake 
of sweet solutions typical for a Western diet [19]. The 
detailed composition of laboratory chow was previously 
published [20]. The animals were housed three per cage 
and kept in a temperature-controlled room (22±2°C) 
with a 12 h light/dark cycle (lights on at 07:00 h) and 
constant humidity. During 9 weeks of treatment, food 
and liquid intake was measured daily. Energy intake 
was calculated as the sum of calories ingested in the 
form of food and liquid. At the end of the treatment, all 
animals were killed by rapid decapitation after overnight 
fasting during which both experimental groups were 
provided only with drinking water. Female rats were 
killed in the diestrus phase of the estrous cycle, which 
was determined by analysis of vaginal smears. Body, 
liver and visceral adipose tissue mass were weighed 
immediately after sacrifice. All animal procedures were 
in compliance with the EEC Directive 2010/63/EU on 
the protection of animals used for scientific purposes, 
and were approved by the Ethical Committee for the 
Use of Laboratory Animals of the Institute for Biologi-
cal Research “Siniša Stanković”, University of Belgrade.
Blood plasma preparation, tissue collection and 
determination of biochemical parameters
After overnight fasting, the animals were killed by rapid 
decapitation. The livers were perfused with cold 0.9% 
NaCl, quickly excised and stored in liquid nitrogen 
until use. Liver triglycerides were isolated from 100 
mg of liver tissue by the modified Folch method [21] 
and analyzed according to Fletcher [22]. Blood glucose 
and triglyceride concentrations were determined in 
the blood immediately after sacrifice using MultiCare 
strips (Biochemical Systems International, Arezzo, 
Italia). Plasma was isolated by blood centrifugation at 
1600xg for 10 min at room temperature and stored at 
-70°C for subsequent processing. The plasma level of 
FFA was determined by a modified version of Dun-
combe’s [23] method.
Preparation of hepatic nucleosols and whole cell 
extracts
Livers were weighed and homogenized using a Janke-
Kunkel Ultra Turrax in 4 vol (w/v) of ice-cold homog-
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enization buffer (20 mM Tris-HCl pH 7.2, 10% glycerol, 
50 mM NaCl, 1 mM EDTA-Na2, 1 mM EGTA-Na2, 2 
mM DTT, protease and phosphatase inhibitors). The 
homogenates were further processed to obtain nucleo-
sols as previously described [24]. For preparation of 
whole cell extracts, the livers were homogenized with 
ice-cold RIPA buffer (50 mM Tris-HCl pH 7.2, 1 mM 
EDTA-Na2, 150 mM NaCl, 0.1% SDS, 1% Nonidet P-40, 
0.5% sodium deoxycholate, 2 mM DTT, protease and 
phosphatase inhibitors). The homogenates were soni-
cated (3x5 s, 1 A, 50/60 Hz), incubated for 60 min on 
ice with continuous agitation and frequent vortexing, 
centrifuged (16000xg, 20 min, 4°C) and stored at -70°C.
Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) and immunoblotting
After boiling in Laemmli’s sample buffer, 40 µg of 
liver proteins were resolved on 7.5% or 10% SDS-
polyacrylamide gels. Western transfer of proteins 
from gels to PVDF membranes was performed in 25 
mM Tris buffer, pH 8.3, containing 192 mM glycine 
and 20% (v/v) methanol, at 135 mA overnight in a 
Mini Trans-Blot Electrophoretic Transfer Cell (Bio-
Rad Laboratories, Hercules, CA, USA). The mem-
branes were blocked by PBS (1.5 mM KH2PO4, 6.5 
mM Na2HPO4, 2.7 mM KCl, 0.14 M NaCl, pH 7.2) 
containing 1% non-fat milk, incubated by rocking 
(1.5 h, room temperature) with the respective primary 
antibodies (Santa Cruz Biotechnology, Dallas, TX, 
USA): anti-PPARα (sc-9000), anti-PGC-1α (sc-13067), 
anti-lipin-1 (sc-98450) and anti-CPT1 (sc-139482). 
Beta-actin (AC-15, Sigma-Aldrich, St. Louis, MO, 
USA) was used as an equal load control. After washing 
with PBS containing 0.1% Tween 20, the membranes 
were incubated with appropriate alkaline phosphatase-
conjugated secondary antibody (Amersham Pharmacia 
Biotech, Little Chalfont, UK). Immunopositive bands 
were visualized by the enhanced chemifluorescence 
(ECF) method and quantified by ImageQuant software 
(GE Healthcare, Little Chalfont, UK).
RNA isolation, reverse transcription  
and real-time PCR
Total RNA was extracted using TRI Reagent® (Am-
Bion Inc., Austin, TX, USA). RNA was dissolved 
in RNase-DNase-free water (Eppendorf, Hamburg, 
Germany) and its concentration and purity were 
tested spectrophotometrically (OD 260/280>1.8 was 
considered satisfactory). RNase inhibitor (Applied 
Biosystems, Foster City, CA, USA) was added and 
the samples were frozen at -70˚C until use. Prior to 
cDNA synthesis, DNA contamination was removed by 
DNase I treatment (Fermentas, Waltham, MA, USA). 
cDNA was synthesized from 2 µg of RNA. Reverse 
transcription was performed using the High-Capacity 
cDNA Reverse Transcription Kit (Applied Biosystems, 
Foster City, CA, USA), according to the manufacturer’s 
instructions, and cDNA was stored at -70°C until use. 
Quantification of target gene expression in the liver 
was performed by TaqMan® real-time PCR. Primers 
and probes for ACC1 (Rn00573474_m1), FAS (Rn 
01463550_m1) and SREBP-1c (Rn01495769_m1) were 
obtained from Applied Biosystems Assay-on-Demand 
Gene Expression Products. HPRT1 (Rn01455646_m1) 
was used as a previously validated endogenous control. 
Statistical analysis
A Student’s unpaired t-test (two-tailed) was used to 
compare the differences between the experimental 
groups. Statistical analyses were performed using 
GraphPad Prism v.5 (GraphPad Software, Inc., La 
Jolla, CA, USA). A probability level less than 0.05 was 
considered to be statistically significant. The data are 
presented as means±SEM.
RESULTS
The effects of a fructose-rich diet on physiological 
and biochemical parameters
On a daily basis, fructose-fed male rats consumed 
more energy in comparison to males maintained on 
a standard diet (Table 1, P<0.05). The excess energy 
originated from fructose since these animals ate less 
chow than those on a standard diet (Table 1, P<0.05). 
Despite the increased energy intake, the fructose-rich 
diet had no effect on body and liver mass, the liver to 
body ratio, nor on the visceral adipose tissue mass and 
visceral adipose tissue to body ratio (Table 1). While 
blood triglycerides and plasma FFA levels were elevated 
in male rats subjected to a fructose-rich diet (Table 1, 
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P<0.05), the level of hepatic triglycerides remained 
unaltered after the treatment (Table 1).
Similar to males, the fructose-fed females consumed 
less chow than females maintained on a standard 
diet (Table 2, P<0.01), and total energy intake was 
increased due to calories from the fructose solution 
(Table 2, P<0.05). As in males, fructose consumption 
also induced triglyceridemia (P<0.01) in females, but 
did not affect body mass and the liver to body mass 
ratio, nor the hepatic level of triglycerides. However, 
in contrast to males, in females the liver mass, visceral 
adipose tissue mass and visceral adipose tissue to body 
ratio were increased (Table 2, P<0.05), while plasma 
FFA levels remained unchanged after the long-term 
fructose diet (Table 2).
The effects of a fructose-rich diet on hepatic de 
novo lipogenesis and β-oxidation of fatty acids
To explore the effects of a long-term fructose-rich 
diet on hepatic de novo lipogenesis, we determined 
the mRNA level of transcription factor SREBP-1c and 
its target genes, ACC1 and FAS, coding for two rate-
limiting lipogenic enzymes. In both sexes, statistically 
significant increases in mRNA levels of SREBP-1c 
(P<0.05 for males, P<0.01 for females), ACC1 (P<0.01 
for males, P<0.05 for females) and FAS (P<0.05) were 
observed in fructose-fed rats when compared to the 
respective controls (Figs. 1 and 3). As for β-oxidation 
of fatty acids, statistically significant increases in the 
nuclear levels of transcription factors PPARα (P<0.05), 
PGC-1α (P<0.01) and lipin-1 (P<0.01), as well as in 
the level of their target gene, CPT1 (P<0.001), were 
observed in fructose-fed male rats when compared 
to males maintained on a standard diet (Fig. 2). In 
contrast to males, there was no significant difference 
in the protein levels of PPARα, PGC-1α, lipin-1 and 
CPT1 between female rats maintained on fructose-rich 
and standard diets (Fig. 4).
DISCUSSION
Fructose has been shown to affect lipid metabolism 
in a way that can result in obesity and hepatic lipid 
accumulation [2]. However, it has not been studied 
whether the fructose-related occurrence of fatty liver 
is sex-dependent. Under physiological conditions, 
Table 1. Food, liquid and energy intake and physiological and bio-








Body mass (g) 339±13 311±13
Mass of liver (g) 12.48±0.69 10.77±0.49
Liver-to-body mass ratio (x100) 3.65±0.09 3.48±0.15
Mass of visceral adipose 
tissue (g) 2.59±0.40 3.16±0.64
Visceral adipose  
tissue-to-body ratio ( x100) 0.75±0.10 1.01±0.17
FFA (mmol/L) 0.61±0.03 0.70±0.02*
Triglycerides (mmol/L) 1.63±0.10 2.07±0.08*
Triglycerides in the liver 
(µmol/g) 20.40±1.20 16.30±1.50
The data are presented as the means±SEM (n=9 animals per group). 
Comparisons between fructose-fed and control rats were made by 
unpaired Student’s t-test. A value of P<0.05 was considered statistically 
significant. Asterisks indicate significant differences. *P<0.05.
Table 2. Food, liquid and energy intake, and physiological and 









Body mass (g) 259.00±7.95 271.23±7.06
Mass of liver (g) 7.93±0.27 9.37±0.49*
Liver-to-body mass ratio (x100) 3.07±0.09 3.41±0.25
Mass of visceral adipose  
tissue (g) 3.20±0.37 5.06±0.72*
Visceral adipose tissue-to-body 
ratio ( x100) 1.24±0.15 1.82±0.22*
FFA (mmol/L) 0.84±0.05 0.83±0.06
Triglycerides (mmol/L) 1.39±0.09 1.87±0.12**
Triglycerides in the liver 
(µmol/g) 34.85±2.88 36.78±1.92
The data are presented as the means±SEM (n=9 animals per group). 
Comparisons between fructose-fed and control rats were made by 
unpaired Student’s t-test. A value of P<0.05 was considered statistically 
significant. Asterisks indicate significant differences. *P<0.05, **P<0.01.
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hepatic triglyceride levels are maintained by a precise 
balance between FFA uptake from plasma and de novo 
lipogenesis vs. triglyceride disposal through fatty acid 
oxidation or lipoprotein secretion. The pathological 
lipid accumulation in the liver could occur as a con-
sequence of an imbalance between these processes.
In the current study, the fructose-rich diet induced 
hypertriglyceridemia and increased hepatic de novo 
lipogenesis in both male and female rats, without lipid 
deposition in the liver. However, this was concurrent 
with the development of adiposity only in females, 
while a parallel increase in hepatic fatty acid β-oxidation 
Fig. 3. The effect of a 10% fructose diet on hepatic de novo lipo-
genesis in young female rats. The levels of SREBP-1c, ACC1 and 
FAS mRNAs relative to HPRT mRNA in the liver of control (C) 
and fructose-fed (F) females was determined by TaqMan real-time 
PCR and presented as the fold-change with respect to the control. 
The values represent the means±SEM (n=9). All measurements 
were done in triplicate. Statistical significance (Student’s t-test) 
of differences between experimental groups: *P<0.05; **P<0.01.
Fig. 4. The effect of a 10% fructose diet on hepatic fatty acid oxida-
tion in young female rats. Relative integrated optical density of the 
immunoreactive bands corresponding to PPARα, PGC-1α, lipin-1 
and CPT1 in the livers of control (C) and fructose-fed (F) females 
was assessed by ImageQuant software, normalized to β-actin and 
expressed as the fold-change with respect to the control. The values 
represent the means±SEM (n=9).
Fig. 1. The effect of a 10% fructose diet on hepatic de novo lipo-
genesis in young male rats. The level of SREBP-1c, ACC1 and 
FAS mRNAs relative to HPRT mRNA in the liver of control (C) 
and fructose-fed (F) males was determined by TaqMan real-time 
PCR and presented as the fold-change with respect to the control. 
The values represent the means±SEM (n=9). All measurements 
were done in triplicate. Statistical significance (Student’s t-test) 
of differences between experimental groups: *P<0.05; **P<0.01.
Fig. 2. The effect of a 10% fructose diet on hepatic fatty acid 
oxidation in young male rats. Relative integrated optical density 
of the immunoreactive bands corresponding to PPARα, PGC-1α, 
lipin-1 and CPT1 in the liver of control (C) and fructose-fed (F) 
males was assessed by ImageQuant software, normalized to β-actin 
and expressed as the fold-change with respect to the control. The 
values represent the means±SEM (n=9). Statistical significance 
(Student’s t-test) of differences between experimental groups: 
*P<0.05; **P<0.01; ***P<0.001.
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was exhibited in male rats. These results imply that 
male and female rats employed different strategies 
to cope with the energy overload originating from a 
fructose-rich diet.
In our study, elevated caloric intake related to 
fructose overconsumption was not followed by an 
increase in body mass. Similar findings were reported 
in some previously published studies [7,25-27], while 
other authors have reported an increase in body mass 
[28,29]. These discrepancies could be attributed to 
differences in experimental settings, such as treatment 
duration, fructose concentration and the form in which 
the fructose was consumed (liquid vs. solid food), as 
well as the age of the experimental animals. As young 
and adult organisms differ largely in their metabolic 
and physiological profiles, it could be assumed that 
responses to fructose overconsumption in youth and 
adulthood would be different. De Moura [25] reported 
that a high fructose intake is more effective at inducing 
signs of the metabolic syndrome, including glucose 
intolerance, insulin resistance, hypertriglyceridemia, 
dyslipidemia and high concentrations of total liver 
lipids in adult (90-day-old at the beginning of the 
treatment) than in young (28-day-old at the beginning 
of the treatment) male Wistar rats, implying protective 
mechanisms specific for young individuals.
One of the most consistently reported effects of 
fructose overconsumption is hypertriglyceridemia 
[7,25,28,29]. Our results showing elevated plasma tri-
glycerides in both sexes indicate that the same applies 
to young rats independent of gender. The observed 
hypertriglyceridemia is likely a consequence of dietary 
fructose-related stimulation of hepatic de novo lipogen-
esis. Namely, in accordance with other studies [26,29], 
fructose overconsumption upregulated the hepatic 
expression of lipogenic transcription factor SREBP-
1c and lipogenic enzymes ACC1 and FAS, although 
lipid accumulation in the liver was not observed. As 
mentioned above, triglycerides could accumulate in the 
liver as a result of elevated hepatic lipid uptake, elevated 
de novo lipogenesis and/or reduced fatty acid oxida-
tion or lipid export. Fructose-induced hepatic lipid 
accumulation was mostly studied in adult male rats, 
and was attributed to increased lipogenesis concur-
rent with reduced fatty acid β-oxidation [29, 30]. In 
our study, increased de novo lipogenesis in the liver of 
young fructose-fed male rats occurred simultaneously 
with the induction of fatty acid oxidation, as evidenced 
by increased nuclear accumulation of PPARα, PGC-1α 
and lipin-1, and a parallel raise in CPT1 level. Together 
with triglycerides export, intensified fatty acid oxidation 
contributes to clearance of fructose-derived lipids from 
the liver in males. Upregulation of both lipid synthesis 
and catabolism in the liver was somewhat unexpected, 
but it has been reported in several studies in which the 
effects of antihyperlipidemic drugs were investigated in 
rodents [31,32]. For example, simultaneous induction 
of hepatic fatty acid oxidation and de novo lipogenesis 
was observed in mice treated with the PPARα agonist 
fenofibrate [31,32]. Stimulated β-oxidation might be 
a part of the metabolic response to increased influx 
of fatty acids to the liver, considering the elevated 
plasma FFA level in male fructose-fed rats. Namely, 
as demonstrated in our previously-published paper, 
a fructose-rich diet stimulated lipolysis in visceral 
adipose tissue, thus leading to elevated plasma FFA 
levels [33] rather than to visceral adipose tissue accu-
mulation. Elevated triglycerides derived from fructose 
catabolism together with FFAs originating from adipose 
tissue lipolysis may expose young male rats to the risk 
of ectopic lipid accumulation and lipotoxicity [34]. 
Under lipid overload, the activation of β-oxidation 
could protect the liver from lipid accumulation. As 
reviewed in [34], several studies on different rodent 
models of metabolic syndrome demonstrated that the 
enhancement of fatty acid oxidation could attenuate 
or even completely prevent an ectopic accumula-
tion of lipids and, consequently, development of the 
correlated disorder. Nonetheless, the possibility that 
prolonged fructose overconsumption might ultimately 
lead to hepatic lipid accumulation and contribute to 
the progression of metabolic disorders in later adult-
hood cannot be ruled out.
Young females seem to apply a different strategy to 
cope with energy overload originating from fructose 
and to avoid lipid accumulation in the liver. Namely, in 
contrast to male rats, the fructose-related enhancement 
of lipogenesis and the consequent increase in plasma 
triglyceride level caused enlargement of visceral adipose 
tissue in females. As previous data from our labora-
tory showed [35], dietary fructose led to triglyceride 
accumulation in visceral adipose tissue, without an 
increase in lipolysis, enabling the retention of lipids in 
adipose tissue and the maintenance of circulating FFA 
concentrations at the control level. It was proposed that 
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the ability of adipocytes to accommodate the caloric 
surplus of overnutrition can minimize ectopic lipid 
accumulation [34]. Indeed, the TG content in the liver 
of fructose-fed female rats remained unaltered despite 
increased de novo lipogenesis. It seems that, since the 
level of FFAs in the plasma of fructose-fed females 
was not increased, their liver was not challenged by 
the lipid surplus to the extent it was in males, and thus 
hepatic fatty acid oxidation in female rats was not 
stimulated. It should be kept in mind that the visceral 
adipose tissue can protect from ectopic lipid deposition 
only to a certain extent, after which enlargement of 
this tissue poses a greater risk for the development of 
metabolic disturbances. This implies that prolonged 
fructose feeding could ultimately disrupt the ability of 
visceral adipose tissue to deal with large amounts of 
lipids, thus contributing to the development of further 
metabolic disturbances.
In conclusion, our results on young rats revealed 
sex-specific effects of a fructose-enriched diet on 
hepatic lipid metabolism. Although the fructose-
enriched diet induced hepatic de novo lipogenesis 
and consequent hypertriglyceridemia in both sexes, 
males and females deployed different mechanisms to 
cope with the energy overload and avoid hepatic lipid 
deposition. In male rats, the diet regime stimulated 
hepatic fatty acid oxidation as part of the metabolic 
response to excess adipose-derived FFA, while in 
females, fructose-promoted adiposity prevented the 
release of FFA, thus creating circumstances that do 
not challenge hepatic fatty acid oxidation. These re-
sults also imply that sex-related differences in plasma 
FFA levels emphasize the importance of a cross-talk 
between adipose tissue and the liver in adaptation to 
diet-induced energy overload.
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